Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT04314687

Stem Cell and Conditioned Medium for Cerebral Palsy

Allogeneic Umbilical Cord Mesenchymal Stem Cells and Conditioned Medium for Cerebral Palsy in Children

Status
Active Not Recruiting
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
78 (estimated)
Sponsor
PT. Prodia Stem Cell Indonesia · Industry
Sex
All
Age
6 Months – 3 Years
Healthy volunteers
Not accepted

Summary

The aim of this study was to compare the effectiveness of umbilical cord mesenchymal stem cells (UCMSCs) and conditioned medium (CM) administration, UCMSCs only and control with standard therapy. Hypothesis: UCMSCs + CM therapy resulting in higher improvement in cognitive function, gross motor function and chemical factors than UCMSCs and standard therapy.

Conditions

Interventions

TypeNameDescription
BIOLOGICALUmbilical Cord Mesenchymal Stem CellsThe umbilical cord was removed from the donor and brought to cell culture facility immediately. Upon arrival, pre-sterility sample testing was performed to ensure the sample was free from contaminant. Culture processes were conducted in a laboratory room where high sterility and safety were guaranteed. Every batch of the cells was monitored by a series of quality control testing to assure the quality of the product.
BIOLOGICALConditioned MediumConditioned medium collected from umbilical cord mesenchymal stem cell (UC-MSC) cultured. Every batch of the conditioned medium was monitored by a series of quality control testing to assure the quality of the product.
OTHERStandard TherapyStandard therapy for cerebral palsy such as physiotherapy

Timeline

Start date
2021-10-13
Primary completion
2026-07-01
Completion
2026-12-01
First posted
2020-03-19
Last updated
2026-02-25

Locations

1 site across 1 country: Indonesia

Source: ClinicalTrials.gov record NCT04314687. Inclusion in this directory is not an endorsement.